ArticleScientific reports2023

Synthesis, molecular docking, and in vivo antidiabetic evaluation of new benzylidene-2,4-thiazolidinediones as partial PPAR-γ agonists.

Asim Najmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.